FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1832334802> ?p ?o ?g. }

• W1832334802 endingPage "845" @default.
• W1832334802 startingPage "840" @default.
• W1832334802 abstract "Abstract Background Patients with metastatic osteosarcoma at diagnosis or axial primary tumors have a poor prognosis. The aim of the study was to evaluate the feasibility and efficacy of intensified treatment with high‐dose chemotherapy (HDCT) and stem cell rescue in this group. Methods From May 1996 to August 2004, 71 patients were included in a Scandinavian‐Italian single arm phase II study. Preoperative chemotherapy included methotrexate, doxorubicin, cisplatin and ifosfamide, and postoperative treatment consisted of two cycles of doxorubicin, one cycle of cyclophosphamide and etoposide and two courses of high‐dose etoposide and carboplatin with stem cell rescue. Results Twenty‐nine patients (43%) received two courses and 10 patients (15%) received one course of HDCT. HDCT was associated with significant toxicity, but no treatment‐related deaths were recorded. Fourteen patients (20%) had disease progression before completion of the study protocol, and only 29/71 patients (41%) received the full planned treatment. Median event‐free survival (EFS) was 18 months, and estimated 5‐year EFS was 27%. Median overall survival (OS) was 34 months, and estimated 5‐year OS was 31%. When patients who did not receive HDCT due to disease progression were excluded, there was no difference in EFS ( P = 0.72) or OS ( P = 0.49) between patients who did or did not receive HDCT. Conclusions The administration of high‐dose chemotherapy with stem cell rescue was feasible, but associated with significant toxicity. Patient outcome seemed comparable to previous studies using conventional chemotherapy. We conclude that HDCT with carboplatin and etoposide should not be further explored as a treatment strategy in high‐risk osteosarcoma. Pediatr Blood Cancer 2014;61:840–845. © 2013 Wiley Periodicals, Inc." @default.
• W1832334802 created "2016-06-24" @default.
• W1832334802 creator A5003714110 @default.
• W1832334802 creator A5023055484 @default.
• W1832334802 creator A5037999437 @default.
• W1832334802 creator A5041193748 @default.
• W1832334802 creator A5050932223 @default.
• W1832334802 creator A5052766014 @default.
• W1832334802 creator A5053457269 @default.
• W1832334802 creator A5073707704 @default.
• W1832334802 creator A5089814370 @default.
• W1832334802 creator A5090145105 @default.
• W1832334802 date "2013-11-20" @default.
• W1832334802 modified "2023-10-06" @default.
• W1832334802 title "High-dose chemotherapy with stem cell rescue in the primary treatment of metastatic and pelvic osteosarcoma: Final results of the ISG/SSG II study" @default.
• W1832334802 cites W146224257 @default.
• W1832334802 cites W146907812 @default.
• W1832334802 cites W1486751599 @default.
• W1832334802 cites W174143014 @default.
• W1832334802 cites W1762813577 @default.
• W1832334802 cites W1954845453 @default.
• W1832334802 cites W1963778334 @default.
• W1832334802 cites W1967903087 @default.
• W1832334802 cites W1978141358 @default.
• W1832334802 cites W1990541466 @default.
• W1832334802 cites W1995250441 @default.
• W1832334802 cites W2011551652 @default.
• W1832334802 cites W2014164262 @default.
• W1832334802 cites W2016053268 @default.
• W1832334802 cites W2018217408 @default.
• W1832334802 cites W2026102568 @default.
• W1832334802 cites W2048202218 @default.
• W1832334802 cites W2048503983 @default.
• W1832334802 cites W2069996052 @default.
• W1832334802 cites W2100055648 @default.
• W1832334802 cites W2102927027 @default.
• W1832334802 cites W2104070754 @default.
• W1832334802 cites W2109740762 @default.
• W1832334802 cites W2121769039 @default.
• W1832334802 cites W2127748864 @default.
• W1832334802 cites W2161522889 @default.
• W1832334802 cites W2164614740 @default.
• W1832334802 cites W2425621570 @default.
• W1832334802 cites W2591598267 @default.
• W1832334802 cites W2983799568 @default.
• W1832334802 cites W4247996565 @default.
• W1832334802 doi "https://doi.org/10.1002/pbc.24868" @default.
• W1832334802 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24254749" @default.
• W1832334802 hasPublicationYear "2013" @default.
• W1832334802 type Work @default.
• W1832334802 sameAs 1832334802 @default.
• W1832334802 citedByCount "39" @default.
• W1832334802 countsByYear W18323348022015 @default.
• W1832334802 countsByYear W18323348022016 @default.
• W1832334802 countsByYear W18323348022017 @default.
• W1832334802 countsByYear W18323348022018 @default.
• W1832334802 countsByYear W18323348022019 @default.
• W1832334802 countsByYear W18323348022020 @default.
• W1832334802 countsByYear W18323348022021 @default.
• W1832334802 countsByYear W18323348022022 @default.
• W1832334802 countsByYear W18323348022023 @default.
• W1832334802 crossrefType "journal-article" @default.
• W1832334802 hasAuthorship W1832334802A5003714110 @default.
• W1832334802 hasAuthorship W1832334802A5023055484 @default.
• W1832334802 hasAuthorship W1832334802A5037999437 @default.
• W1832334802 hasAuthorship W1832334802A5041193748 @default.
• W1832334802 hasAuthorship W1832334802A5050932223 @default.
• W1832334802 hasAuthorship W1832334802A5052766014 @default.
• W1832334802 hasAuthorship W1832334802A5053457269 @default.
• W1832334802 hasAuthorship W1832334802A5073707704 @default.
• W1832334802 hasAuthorship W1832334802A5089814370 @default.
• W1832334802 hasAuthorship W1832334802A5090145105 @default.
• W1832334802 hasConcept C126322002 @default.
• W1832334802 hasConcept C141071460 @default.
• W1832334802 hasConcept C142724271 @default.
• W1832334802 hasConcept C143998085 @default.
• W1832334802 hasConcept C2776694085 @default.
• W1832334802 hasConcept C2776755627 @default.
• W1832334802 hasConcept C2777506904 @default.
• W1832334802 hasConcept C2777760704 @default.
• W1832334802 hasConcept C2778119113 @default.
• W1832334802 hasConcept C2778239845 @default.
• W1832334802 hasConcept C2781303535 @default.
• W1832334802 hasConcept C2781451048 @default.
• W1832334802 hasConcept C71924100 @default.
• W1832334802 hasConceptScore W1832334802C126322002 @default.
• W1832334802 hasConceptScore W1832334802C141071460 @default.
• W1832334802 hasConceptScore W1832334802C142724271 @default.
• W1832334802 hasConceptScore W1832334802C143998085 @default.
• W1832334802 hasConceptScore W1832334802C2776694085 @default.
• W1832334802 hasConceptScore W1832334802C2776755627 @default.
• W1832334802 hasConceptScore W1832334802C2777506904 @default.
• W1832334802 hasConceptScore W1832334802C2777760704 @default.
• W1832334802 hasConceptScore W1832334802C2778119113 @default.
• W1832334802 hasConceptScore W1832334802C2778239845 @default.
• W1832334802 hasConceptScore W1832334802C2781303535 @default.
• W1832334802 hasConceptScore W1832334802C2781451048 @default.
• W1832334802 hasConceptScore W1832334802C71924100 @default.

• next